Zobrazeno 1 - 10
of 4 868
pro vyhledávání: '"Vassal, G"'
Autor:
Vassal, G., Kozhaeva, O., Griskjane, S., Arnold, F., Nysom, K., Basset, L., Kameric, L., Kienesberger, A., Kamal, S., Cherny, N., Bricalli, G., Latino, N., Kearns, P.
Publikováno v:
In Annals of Oncology April 2021 32(4):560-568
Autor:
Geoerger B; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France; Gustave Roussy Cancer Campus, INSERM U1015, Université Paris-Saclay, Villejuif, France. Electronic address: birgit.geoerger@gustaveroussy.fr., Bautista F; Hospital Niño Jesús, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Madrid, Spain; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., André N; Hôpital de la Timone, Department of Pediatric Oncology, AP-HM, Marseille, France; UMR INSERM 1068, CNRS UMR 7258, Aix Marseille Université U105, Marseille Cancer Research Center (CRCM), France; Metronomics Global Health Initiative, Marseille, France., Berlanga P; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France., Gatz SA; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Marshall LV; Royal Marsden Hospital NHS Foundation Trust Paediatric and Adolescent Oncology Drug Development Unit, and & The Institute of Cancer Research, Division of Clinical Studies, London, United Kingdom., Rubino J; Gustave Roussy Cancer Campus, Clinical Research Direction, Université Paris-Saclay, Villejuif, France., Archambaud B; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France; Gustave Roussy Cancer Campus, Office of Biostatistics and Epidemiology, Université Paris-Saclay, Villejuif, France, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France., Marchais A; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France; Gustave Roussy Cancer Campus, INSERM U1015, Université Paris-Saclay, Villejuif, France., Rubio-San-Simón A; Hospital Niño Jesús, Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Madrid, Spain., Ducassou S; Centre Hospitalier Universitaire Pellegrin - Hôpital des Enfants, Bordeaux, France., Zwaan CM; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Casanova M; Fondazione IRCCS Istituto Nazionale dei Tumori, Pediatric Oncology Unit, Milan, Italy., Nysom K; Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Pellegrino S; Gustave Roussy Cancer Campus, Clinical Research Direction, Université Paris-Saclay, Villejuif, France., Hoog-Labouret N; Institut National de Cancer, Boulogne, France., Buzyn A; Institut National de Cancer, Boulogne, France., Blanc P; Association Imagine for Margo, Paris, France., Paoletti X; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France; Gustave Roussy Cancer Campus, Office of Biostatistics and Epidemiology, Université Paris-Saclay, Villejuif, France, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France., Vassal G; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France; Gustave Roussy Cancer Campus, Clinical Research Direction, Université Paris-Saclay, Villejuif, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 208, pp. 114201. Date of Electronic Publication: 2024 Jul 14.
Autor:
Pearson AD; ACCELERATE, Europe, Belgium. Electronic address: andy1pearson@btinternet.com., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA., Macy ME; Childrens' Hospital, CO, USA., de Rojas T; ACCELERATE, Europe, Belgium., Donoghue M; US Food and Drug Administration, Silver Springs, MD, USA., Weiner S; Children's Cancer Cause, Washington, DC, USA., Knoderer H; Loxo Oncology at Lilly, USA., Bernardi R; Genentech, A Member of the Roche Group, South San Francisco, CA USA., Buenger V; Coalition Against Childhood Cancer (CAC2), Philadelphia, USA., Canaud G; Necker Enfants Malades Hospital, Paris, France., Cantley L; Harvard Medical School, Boston, USA., Chung J; Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA., Fox E; St Jude Children's Research Hospital, TN, USA., Friend J; Kazia Therapeutics, NJ, USA., Glade-Bender J; Memorial Sloan Kettering Cancer Centre, New York, USA., Gorbatchevsky I; Celcuity Inc., Minneapolis, MN, USA., Gore L; Childrens' Hospital, CO, USA., Gupta A; The Hospital for Sick Children (SickKids), Princess Margaret Hospital Toronto, Canada., Hawkins DS; Seattle Children's Hospital, Seattle, USA., Juric D; Massachusetts General Hospital, Boston, USA., Lang LA; Rally Foundation for Childhood Cancer Research, Atlanta, GA, USA., Leach D; National Brain Tumor Society, Newton, MA, USA., Liaw D; Merck Sharp & Dohme, NJ, USA., Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), the Netherlands., Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), the Netherlands., Lindberg G; The EVAN Foundation, Germantown, MD, USA., Lindberg W; The EVAN Foundation, Germantown, MD, USA., Ludwinski D; Solving Kids' Cancer, New York, USA., Marshall L; The Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK., Mazar A; Actuate Therapeutics Inc., For worth, TX, USA., McDonough J; The Andrew McDonough B+ Foundation, Wilmington, DE, USA., Nysom K; Righospitalet, Copenhagen, Denmark., Ours C; National Human Genome Research Institute/National Institutes of Health, MD, USA., Pappo A; St Jude Children's Research Hospital, TN, USA., Parsons DW; Texas Children's Cancer and Hematology Center, TX, USA., Rosenfeld A; AstraZeneca, Waltham, MA, USA., Scobie N; Zoe4Life, Sullens, Switzerland., Smith M; National Cancer Institute, MD, USA., Taylor D; PORT (Paediatric Oncology Reference Team), London, UK., Weigel B; University of Minnesota, Minneapolis, USA., Weinstein A; Pediatric Brain Tumor Foundation of the US, Atlanta, USA., Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), the Netherlands., Vassal G; ACCELERATE, Europe, Belgium; Gustave Roussy Cancer Centre, Paris, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114145. Date of Electronic Publication: 2024 Jun 08.
Autor:
Moro-Sibilot, D. *, Cozic, N., Pérol, M., Mazières, J., Otto, J., Souquet, P.J., Bahleda, R., Wislez, M., Zalcman, G., Guibert, S.D., Barlési, F., Mennecier, B., Monnet, I., Sabatier, R., Bota, S., Dubos, C., Verriele, V., Haddad, V., Ferretti, G., Cortot, A., De Fraipont, F., Jimenez, M., Hoog-Labouret, N., Vassal, G.
Publikováno v:
In Annals of Oncology December 2019 30(12):1985-1991
Autor:
Bautista F; Division of Pediatric Hematology and Oncology, Hospital Universitario Niño Jesús, Madrid, Spain.; Princess Máxima Center, Utrecht, the Netherlands., Verdú-Amorós J; Division of Pediatric Hematology and Oncology, Hospital Universitario Niño Jesús, Madrid, Spain.; Division of Pediatric Hematology and Oncology, Hospital Clínico Universitario de Valencia, Biomedical Research Institute, INCLIVA, Valencia, Spain., Geoerger B; Pediatric and Adolescent Oncology Department, Gustave Roussy Cancer Campus, INSERM U1015, Université Paris-Saclay, Villejuif, France., Rubio-San-Simón A; Division of Pediatric Hematology and Oncology, Hospital Universitario Niño Jesús, Madrid, Spain., Paoletti X; Institut Curie & Université Versailles St Quentin & INSERM U900 STAMPM, Paris, France., Zwaan CM; Princess Máxima Center, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Casanova M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Marshall LV; Pediatric and Adolescent Oncology Drug Development, Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Carceller F; Pediatric and Adolescent Oncology Drug Development, Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Doz F; SIREDO Cancer Center (Care, Innovation and Research in Pediatric, Adolescents, and Young Adults Oncology), Curie Institute Paris, and University Paris Cité, Paris, France., Lecinse C; Innovative Therapies for Children with Cancer, Gustave Roussy Cancer Campus, Villejuif, France., Vassal G; Innovative Therapies for Children with Cancer, Gustave Roussy Cancer Campus, Villejuif, France., Pearson ADJ; Pediatric and Adolescent Oncology Drug Development, Children & Young People's Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Kearns P; Institute of Cancer and Genomic Sciences, NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, United Kingdom., Moreno L; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 20; Vol. 42 (21), pp. 2516-2526. Date of Electronic Publication: 2024 May 14.
Autor:
Raiser P; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France., Schleiermacher G; RTOP (Recherche Translationelle en Oncologie Pediatrique), U830 INSERM, Institut Curie, PSL Research University, 75005 Paris, France; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), U830 INSERM, Institut Curie, PSL Research University, 75005 Paris, France., Gambart M; Department of Pediatric Oncology, Toulouse University Hospital, 31300 Toulouse, France., Dumont B; Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique/Centre Léon Bérard, 69008 Lyon, France., Defachelles AS; Department of Pediatric Oncology, Oscar Lambret Cancer Center, 59000 Lille, France., Thebaud E; Pediatric Immuno-Hemato-Oncology Unit, CHU Nantes, 44000 Nantes, France., Tandonnet J; Pediatric Hematology-Oncology Department, Centre Hospitalier Universitaire (CHU), 33000 Bordeaux, France., Pasqualini C; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France., Proust S; Department of Pediatric Oncology, University Hospital, 49100 Angers, France., Entz-Werle N; Pediatric Onco-Hematology Unit, University Hospital of Strasbourg, 67200 Strasbourg, France., Aerts I; RTOP (Recherche Translationelle en Oncologie Pediatrique), U830 INSERM, Institut Curie, PSL Research University, 75005 Paris, France; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), U830 INSERM, Institut Curie, PSL Research University, 75005 Paris, France., Ndounga-Diakou LA; Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France., Petit A; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, 75012 Paris, France., Puiseux C; Department of Pediatric Hemato-Oncology, University Hospital of Rennes, 35200 Rennes, France., Khanfar C; Department of Pediatric Oncology, CHU Amiens Picardie, 80054 Amiens, France., Rouger J; Department of Pediatric Hematology and Oncology, University Hospital of Caen, 14000 Caen, France., Mansuy L; Department of Pediatric Hematology-Oncology, Children's Hospital of Brabois, 54500 Vandoeuvre Les Nancy, France., Benadiba J; Department of Hemato-Oncology Pediatric, Nice University Hospital, 06000 Nice, France., Millot F; Department of Paediatric Haematology and Oncology, Centre Hospitalo-Universitaire de Poitiers, 86000 Poitiers, France., Pluchart C; Department of Paediatric Haematology and Oncology, Centre Hospitalo-Universitaire de Reims, 51100 Reims, France., Laghouati S; Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France., Geoerger B; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France., Vassal G; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France., Valteau-Couanet D; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France., Berlanga P; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, 94805 Villejuif, France. Electronic address: Pablo.Berlanga@gustaveroussy.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 114001. Date of Electronic Publication: 2024 Mar 11.
Autor:
de Rojas T; ACCELERATE, Brussels, Belgium., Chiodin D; Day One Biopharmaceuticals, Brisbane, California, USA., Pearson ADJ; ACCELERATE, Brussels, Belgium., Heenen D; KickCancer, Brussels, Belgium., Adamson P; Sanofi, Cambridge, Massachusetts, USA., Caron H; Hoffman-La Roche, Basel, Switzerland., Vassal G; ACCELERATE, Brussels, Belgium.; Gustave Roussy Cancer Centre, Villejuif, France.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jan; Vol. 115 (1), pp. 36-41. Date of Electronic Publication: 2023 Nov 14.
Autor:
Gaspar, N., Marshall, L.V., Binner, D., Herold, R., Rousseau, R., Blanc, P., Capdeville, R., Carleer, J., Copland, C., Kerloeguen, Y., Norga, K., Pacaud, L., Sevaux, M.-A., Spadoni, C., Sterba, J., Ligas, F., Taube, T., Uttenreuther-Fischer, M., Chioato, S., O'Connell, M.A., Geoerger, B., Blay, J.-Y., Soria, J.C., Kaye, S., Wulff, B., Brugières, L., Vassal, G., Pearson, A.D.J.
Publikováno v:
In Annals of Oncology March 2018 29(3):766-771
Autor:
Pearson, A.D.J., Federico, S., Gatz, S.A., Ortiz, M., Lesa, G., Scobie, N., Gounaris, I., Weiner, S.L., Weigel, B., Unger, T.J., Stewart, E., Smith, M., Slotkin, E.K., Reaman, G., Pappo, A., Nysom, K., Norga, K., McDonough, J., Marshall, L.V., Ludwinski, D., Ligas, F., Karres, D., Kool, M., Horner, T.J., Henssen, A., Heenen, D., Hawkins, D.S., Gore, L., Bender, J.G., Galluzzo, S., Fox, E., de Rojas, T., Davies, B.R., Chakrabarti, J., Carmichael, J., Bradford, D., Blanc, P., Bernardi, R., Benchetrit, S., Akindele, K., Vassal, G.
DNA damage response inhibitors have a potentially important therapeutic role in paediatric cancers; however, their optimal use, including patient selection and combination strategy, remains unknown. Moreover, there is an imbalance between the number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::1710b7ed5065a0dad58ad299181a3dc3
http://edoc.mdc-berlin.de/23585/1/23585oa.pdf
http://edoc.mdc-berlin.de/23585/1/23585oa.pdf
Autor:
Chaix J; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Schleiermacher G; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Research Center, PSL Research University, Institut Curie, Paris, France; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, PSL Research University, Paris, France., Corradini N; Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique/Centre Léon Bérard, Lyon, France., André N; Department of Pediatric Hematology and Oncology, Hôpital de La Timone, AP-HM, Marseille, France; UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université U105, Marseille Cancer Research Center (CRCM), Marseille, France., Thebaud E; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Nantes, France., Gambart M; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Toulouse, France., Defachelles AS; Department of Pediatric Oncology, Centre Oscar Lambret, Lille, France., Entz-Werle N; Department of Pediatric Oncology, Hospices Civils de Strasbourg, Strasbourg, France., Chastagner P; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Vandoeuvre les Nancy, France., De Carli É; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Angers, France., Ducassou S; Department of Pediatric Oncology, Centre Hospitalier Universitaire, Bordeaux, France., Landman-Parker J; Sorbonne Université APHP, Hôpital A Trousseau Paris, Paris, France., Adam-de-Beaumais T; Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Larive A; Biostatistics and Epidemiology Office, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Saclay, Villejuif, France., Michiels S; Biostatistics and Epidemiology Office, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Saclay, Villejuif, France., Vassal G; Clinical Research Direction, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Valteau-Couanet D; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Geoerger B; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Berlanga P; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Electronic address: Pablo.Berlanga@gustaveroussy.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Apr; Vol. 201, pp. 113923. Date of Electronic Publication: 2024 Feb 15.